Nice to see you again. Yesterday was particularly busy thanks to the ongoing Vytorin controversy and a speaking engagement of our own. Will today be quieter? Unlikely. So as you prepare, here are a few items to help you acclimate. Busy or not, we hope your day is swell...
Mylan CEO Earned $10M In Nine Months Last Year (Pittsburgh Business Journal)
Court Blocks Teva's Generic Prevacid (Bloomberg News)
Appeals Court Backs Ortho-McNeil In Topamax Fight (Yahoo/Reuters)
Dr. Reddy's Buys Two UK Dow Facilities (Bloomberg News)